First published · Last updated
Fragment-based drug discovery strategy reveals an unprecedented allosteric binding site in Mycobacterium tuberculosis DNA gyrase
A peer-reviewed journal article reports that a fragment-based drug discovery approach identified a previously unreported allosteric site on Mycobacterium tuberculosis DNA gyrase. Publisher listed as Elsevier BV with publication date 2026-09-01.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 6/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 4/10
- Positivity
- 7/10
- Urgency
- 2/10
Why it matters
The result may be relevant to tuberculosis drug research and design.

